返回 Agenda
[DIAmond Session 1] Vision of Future Drug Development in Utilizing Next-Generation Medical ICT
Session Chair(s)
Yasuhiro Fujiwara, MD, PHD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshihiko Ono, RPH
Regulatory Executive Advisor, MSD K.K., Japan
Recently, under the Healthcare Policy, discussions are ongoing for Next-Generation Medical ICT on aiming to build and to utilize digital infrastructure in the areas of medical, nursing care, and health care. In this session, we will hold a panel discussion to offer respective views from industrial, academic, and government perspectives on the future direction of Next-Generation Medical ICT, and vision of future Drug Development including utilization or potential impact of ICT on clinical studies or on review for drug approval.
Speaker(s)
Kouji Fujimoto
Deputy Director-General, Office of Health and Medical Policy, Cabinet Secretariat, Japan
Policy and its Aim of Next-Generation Medical Information and Communication Technology (ICT)
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
Vision of Future Drug Development in Utilizing Next-Generation Medical ICT
Tatsuya Kondo, MD, PHD
President, SH Medical Excellence JAPAN, Japan
Drug Development Utilized Next Generation ICT - PMDA’s Efforts -
Tomohiro Sawa, MD, PHD
Professor, Medical Information Systems Research Center, Teikyo University Hospital, Japan